1. Home
  2. CULP vs IXHL Comparison

CULP vs IXHL Comparison

Compare CULP & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

N/A

Current Price

$3.84

Market Cap

52.7M

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.41

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
IXHL
Founded
1972
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Textiles
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
49.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CULP
IXHL
Price
$3.84
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.1K
24.0M
Earning Date
12-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$207,391,000.00
$12,000.00
Revenue This Year
$1.93
N/A
Revenue Next Year
$2.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.42
$0.08
52 Week High
$5.94
$2.25

Technical Indicators

Market Signals
Indicator
CULP
IXHL
Relative Strength Index (RSI) 44.92 55.34
Support Level $3.78 $0.35
Resistance Level $3.95 $0.50
Average True Range (ATR) 0.14 0.04
MACD 0.00 0.01
Stochastic Oscillator 23.46 59.53

Price Performance

Historical Comparison
CULP
IXHL

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: